2,733
Views
23
CrossRef citations to date
0
Altmetric
Review

A Review of the Differential Diagnosis of Acute Infectious Conjunctivitis: Implications for Treatment and Management

&
Pages 805-813 | Published online: 12 Mar 2020

References

  • American Academy of Ophthalmology Cornea/External DiseasePreferred Practice Pattern Panel. Conjunctivitis Preferred Practice Pattern®. San Francisco, CA: American Academy of Ophthalmology; 2018. Available from https://www.aao.org/preferred-practice-pattern/conjunctivitis-ppp-2018. Accessed November 26, 2018.
  • Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA. 2013;310(16):1721–1729. doi:10.1001/jama.2013.280318
  • Shields T, Sloane PD. A comparison of eye problems in primary care and ophthalmology practices. Fam Med. 1991;23(7):544–546.
  • Davis H, Mant D, Scott C, Lasserson D, Rose PW. Relative impact of clinical evidence and over-the-counter prescribing on topical antibiotic use for acute infective conjunctivitis. Br J Gen Pract. 2009;59(569):897–900. doi:10.3399/bjgp09X473132
  • Kaufman HE. Adenovirus advances: new diagnostic and therapeutic options. Curr Opin Ophthalmol. 2011;22(4):290–293. doi:10.1097/ICU.0b013e3283477cb5
  • Udeh BL, Schneider JE, Ohsfeldt RL. Cost effectiveness of a point-of-care test for adenoviral conjunctivitis. Am J Med Sci. 2008;336(3):254–264. doi:10.1097/MAJ.0b013e3181637417
  • Smith AF, Waycaster C. Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States. BMC Ophthalmol. 2009;9:13. doi:10.1186/1471-2415-9-13
  • Ohnsman CM. Exclusion of students with conjunctivitis from school: policies of state departments of health. J Pediatr Ophthalmol Strabismus. 2007;44(2):101–105. doi:10.3928/01913913-20070301-03
  • Rietveld RP, Ter Riet G, Bindels PJ, Sloos JH, van Weert HC. Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms. BMJ. 2004;329(7459):206–210. doi:10.1136/bmj.38128.631319.AE
  • Everitt HA, Little PS, Smith PW. A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice. BMJ. 2006;333(7563):321. doi:10.1136/bmj.38891.551088.7C
  • van Weert HC, Tellegen E, Ter Riet G. A new diagnostic index for bacterial conjunctivitis in primary care. A re-derivation study. Eur J Gen Pract. 2014;20(3):202–208. doi:10.3109/13814788.2013.842970
  • Asbell PA, Sanfilippo CM, Pillar CM, DeCory HH, Sahm DF, Morris TW. Antibiotic resistance among ocular pathogens in the United States: five-year results from the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study. JAMA Ophthalmol. 2015;133(12):1445–1454. doi:10.1001/jamaophthalmol.2015.3888
  • Haas W, Pillar CM, Torres M, Morris TW, Sahm DF. Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study. Am J Ophthalmol. 2011;152(4):567–574. e3. doi:10.1016/j.ajo.2011.03.010
  • Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, Pediatric Infectious Diseases Society. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol. 2012;33(4):322–327. doi:10.1086/665010
  • Rietveld RP, van Weert HC, Ter Riet G, Bindels PJ. Diagnostic impact of signs and symptoms in acute infectious conjunctivitis: systematic literature search. BMJ. 2003;327(7418):789. doi:10.1136/bmj.327.7418.789
  • Sheikh A, Hurwitz B, van Schayck CP, McLean S, Nurmatov U. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2012;9:CD001211.doi:10.1002/14651858.CD001211.pub3
  • Rietveld RP, Ter Riet G, Bindels PJ, Schellevis FG, van Weert HC. Do general practitioners adhere to the guideline on infectious conjunctivitis? Results of the Second Dutch National Survey of General Practice. BMC Fam Pract. 2007;8:54. doi:10.1186/1471-2296-8-54
  • O’Brien TP. Allergic conjunctivitis: an update on diagnosis and management. Curr Opin Allergy Clin Immunol. 2013;13(5):543–549. doi:10.1097/ACI.0b013e328364ec3a
  • Rutala WA, Weber DJ. Selection of the ideal disinfectant. Infect Control Hosp Epidemiol. 2014;35(7):855–865. doi:10.1086/676877
  • Gordon YJ, Gordon RY, Romanowski E, Araullo-Cruz TP. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology. 1993;100(12):1835–1839; discussion 1839–1840. doi:10.1016/S0161-6420(93)31389-8
  • Pihos AM. Epidemic keratoconjunctivitis: a review of current concepts in management. J Optom. 2013;6(2):69–74. doi:10.1016/j.optom.2012.08.003
  • Jhanji V, Chan TC, Li EY, Agarwal K, Vajpayee RB. Adenoviral keratoconjunctivitis. Surv Ophthalmol. 2015;60(5):435–443. doi:10.1016/j.survophthal.2015.04.001
  • Rajaiya J, Chodosh J. New paradigms in infectious eye disease: adenoviral keratoconjunctivitis. Arch Soc Esp Oftalmol. 2006;81(9):493–498.
  • Meyer-Rusenberg B, Loderstadt U, Richard G, Kaulfers PM, Gesser C. Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment. Dtsch Arztebl Int. 2011;108(27):475–480. doi:10.3238/arztebl.2011.0475
  • Romanowski EG, Roba LA, Wiley L, Araullo-Cruz T, Gordon YJ. The effects of corticosteroids of adenoviral replication. Arch Ophthalmol. 1996;114(5):581–585. doi:10.1001/archopht.1996.01100130573014
  • Pepose JS, Ahuja A, Liu W, Narvekar A, Haque R. Randomized, controlled, phase 2 trial of povidone-iodine/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis. Am J Ophthalmol. 2018;194(10):7–15. doi:10.1016/j.ajo.2018.05.012
  • Teuchner B, Nagl M, Schidlbauer A, et al. Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis–a double-blind, randomized, phase-2 clinical trial. J Ocul Pharmacol Ther. 2005;21(2):157–165. doi:10.1089/jop.2005.21.157
  • Sambursky R, Trattler W, Tauber S, et al. Sensitivity and specificity of the AdenoPlus test for diagnosing adenoviral conjunctivitis. JAMA Ophthalmol. 2013;131(1):17–22. doi:10.1001/2013.jamaophthalmol.513
  • Baneke AJ, Lim KS, Stanford M. The pathogenesis of raised intraocular pressure in uveitis. Curr Eye Res. 2016;41(2):137–149. doi:10.3109/02713683.2015.1017650
  • Li JY. Herpes zoster ophthalmicus: acute keratitis. Curr Opin Ophthalmol. 2018;29(4):328–333. doi:10.1097/ICU.0000000000000491
  • O’Brien TP, Jeng BH, McDonald M, Raizman MB. Acute conjunctivitis: truth and misconceptions. Curr Med Res Opin. 2009;25(8):1953–1961. doi:10.1185/03007990903038269
  • Yamaguchi T. Inflammatory response in dry eye. Invest Ophthalmol Vis Sci. 2018;59(14):DES192–DES199. doi:10.1167/iovs.17-23651
  • Blank S, Daskalakis DC. Neisseria gonorrhoeae - rising infection rates, dwindling treatment options. N Engl J Med. 2018;379(19):1795–1797. doi:10.1056/NEJMp1812269
  • Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2017. Gonorrhea. Available from: https://www.cdc.gov/std/stats17/Gonorrhea.htm#ref3. Accessed February 4, 2019.
  • Centers for Disease Control and Prevention. New CDC analysis shows steep and sustained increases in STDs in recent years. August 2018 Press Release. Available from: https://www.cdc.gov/media/releases/2018/p0828-increases-in-stds.html. Accessed February 21, 2019.
  • Workowski KA, Bolan GA;Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1–137.
  • Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2017. Chlamydia. Available from: https://www.cdc.gov/std/stats17/chlamydia.htm. Accessed February 21, 2019.
  • Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2017. Table 1. Sexually transmitted diseases — reported cases and rates of reported cases per 100,000 Population, United States, 1941–2017. Available from: https://www.cdc.gov/std/stats17/tables/1.htm. Accessed February 21, 2019.
  • Gilani CJ, Yang A, Yonkers M, Boysen-Osborn M. Differentiating urgent and emergent causes of acute red eye for the emergency physician. West J Emerg Med. 2017;18(3):509–517. doi:10.5811/westjem.2016.12.31798
  • Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.008
  • Kam KY, Ong HS, Bunce C, Ogunbowale L, Verma S. Sensitivity and specificity of the AdenoPlus point-of-care system in detecting adenovirus in conjunctivitis patients at an ophthalmic emergency department: a diagnostic accuracy study. Br J Ophthalmol. 2015;99(9):1186–1189. doi:10.1136/bjophthalmol-2014-306508
  • Holtz KK, Townsend KR, Furst JW, et al. An assessment of the AdenoPlus point-of-care test for diagnosing adenoviral conjunctivitis and its effect on antibiotic stewardship. Mayo Clin ProcInnov Qual Outcomes. 2017;1(2):170–175. doi:10.1016/j.mayocpiqo.2017.06.001
  • ESwab™. Sample collection, transport & processing. Murrieta, CA: COPANDiagnostics Inc. Available from: http://www.copanusa.com/sample-collection-transport-processing/. Accessed December 14, 2018.
  • Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G. Neonatal conjunctivitis - a review. Malays Fam Physician. 2008;3(2):77–81.
  • Zirgan (ganciclovir ophthalmic gel 0.15%) prescribing information. Bausch and Lomb. Available from: https://www.bausch.com/Portals/69/-/m/BL/United%20States/USFiles/Package%20Inserts/Pharma/zirganpackageinsert.pdf. Accessed December 18, 2018.